Corona Remedies IPO subscribed 137.04 times on final day

• Corona Remedies IPO was subscribed 137.04 times on its final day.
• Qualified Institutional Buyers (QIBs) subscribed 278.52 times, Non Institutional Investors (NIIs) 208.88 times, and Retail Individual Investors (RIIs) 28.73 times.
• The Rs 655.37-crore IPO had a price band of Rs 1,008-1,062 per share.
• The IPO is entirely an Offer For Sale (OFS) by promoters and existing investors.
• Corona Remedies is an Ahmedabad-based pharmaceutical company focusing on women's healthcare, cardio-diabeto, pain management, and urology.

Why It Matters: High IPO subscription shows strong investor confidence in Corona Remedies.